DIABASE; Diabetes Mellitus Registry in Second Care

Ziekenhuisgroep Twente1 site in 1 country1,500 target enrollmentSeptember 11, 2020

ConditionsDiabetes Mellitus

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Diabetes Mellitus
Sponsor: Ziekenhuisgroep Twente
Enrollment: 1500
Locations: 1
Primary Endpoint: Real world data from medical devices and clinical outcome in a registry
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study aims to examine real world data from medical devices and clinical outcome from diabetes mellitus patients to gain the necessary insights to be able to improve individual patient care by building a registry.

Registry

clinicaltrials.gov

Start Date

September 11, 2020

End Date

December 31, 2060

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ziekenhuisgroep Twente

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients with type 1 or type 2 diabetes
•Patients aged 18 years or older
•Patients visiting the outpatient clinic internal medicine in the ZGT Hospital
•Written informed consent

Exclusion Criteria

•Severe general diseases or mental disorders making the participation in the study impossible

Outcomes

Primary Outcomes

Real world data from medical devices and clinical outcome in a registry

Time Frame: 0-30 years

Examine real world data from medical devices and clinical outcome in a registry to gain the necessary insights to be able to improve individual patient care